News | September 15, 2023
Ami Organics to supply additional API to Fermion
The product is expected to start contributing meaningfully to the revenue from FY25
The product is expected to start contributing meaningfully to the revenue from FY25
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Subscribe To Our Newsletter & Stay Updated
